• Issue

    Neuropsychopharmacology Reports: Volume 39, Issue 3

    147-259
    September 2019

ISSUE INFORMATION

Open Access

Issue Information

  • Page: 147
  • First Published: 04 September 2019

REVIEW ARTICLE

Open Access

Alteration in AMPA receptor subunit expression and receptor binding among patients with addictive disorders: A systematic review of human postmortem studies

  • Pages: 148-155
  • First Published: 09 May 2019
Alteration in AMPA receptor subunit expression and receptor binding among patients with addictive disorders: A systematic review of human postmortem studies

Postmortem studies on AMPA receptors in patients with addiction show that the hippocampus and amygdala may be pertinent to addictive disorders through their functions on learning and memory, whereas findings in other regions were inconsistent across the studies. Human postmortem studies are prone to degenerative changes after death, which emphasizes the need to investigate AMPA receptors in the living human brains.

ORIGINAL ARTICLES

Open Access

Antidepressant amitriptyline-induced matrix metalloproteinase-9 activation is mediated by Src family tyrosine kinase, which leads to glial cell line-derived neurotrophic factor mRNA expression in rat astroglial cells

  • Pages: 156-163
  • First Published: 25 April 2019
Antidepressant amitriptyline-induced matrix metalloproteinase-9 activation is mediated by Src family tyrosine kinase, which leads to glial cell line-derived neurotrophic factor mRNA expression in rat astroglial cells

Treatment of rat C6 astroglial cells (C6 cells) with amitriptyline increased Src family tyrosine kinase phosphorylation in a time- and concentration-dependent manner. The current findings suggest that the pharmacological effect of antidepressant such as amitriptyline is mediated through an intracellular signaling pathway via the LPAR1/Gαi/o/Src family tyrosine kinase, which leads to MMP-9 activation and glial cell line-derived neurotrophic factor production.

Open Access

Development of the School Teachers Job Stressor Scale (STJSS)

  • Pages: 164-172
  • First Published: 27 June 2019
Development of the School Teachers Job Stressor Scale (STJSS)

We developed the 23-item “School Teachers Job Stressor Scale (STJSS)” to measure specific stressors in Japanese teachers to improve their mental health care which could provide an accurate assessment tool with adequate reliability and validity.

Open Access

Blonanserin versus haloperidol in Japanese patients with schizophrenia: A phase 3, 8-week, double-blind, multicenter, randomized controlled study

  • Pages: 173-182
  • First Published: 30 April 2019
Blonanserin versus haloperidol in Japanese patients with schizophrenia: A phase 3, 8-week, double-blind, multicenter, randomized controlled study

Blonanserin is as effective as haloperidol for the treatment of schizophrenia. Blonanserin is more effective for negative symptoms with a lower risk of extrapyramidal symptoms compared with haloperidol. Blonanserin is considered an appropriate antipsychotic drug to combine with cognitive remediation therapy.

Open Access

Characteristics of facial muscle activity during voluntary facial expressions: Imaging analysis of facial expressions based on myogenic potential data

  • Pages: 183-193
  • First Published: 28 May 2019
Characteristics of facial muscle activity during voluntary facial expressions: Imaging analysis of facial expressions based on myogenic potential data

With facial myogenic potential topography, facial expressions can be evaluated objectively without being influenced by face shape or countenance. Cluster analysis of the expression of disgust showed four homogeneous subgroups. Color changes in topograms showed subtle changes in expressions that could not be supplemented with statistical processing alone, and these were useful in identifying individuality.

Open Access

Moral competence and conduct disorder among Filipino children in conflict with the law

  • Pages: 194-202
  • First Published: 16 July 2019

This paper examines the relationship between moral competence and conduct disorder among Filipino children in conflict with the law. Aside from the association found between low moral competence and conduct disorder, other associations uncovered in this study include the relationship between conduct disorder and the presence of substance use as a dual diagnosis and history of child abuse. As of the time of publication, this is the first paper of its kind to have been conducted in the Philippines.

Open Access

Regulatory system of mGluR group II in the nucleus accumbens for methamphetamine-induced dopamine increase by the medial prefrontal cortex

  • Pages: 209-216
  • First Published: 08 July 2019
Regulatory system of mGluR group II in the nucleus accumbens for methamphetamine-induced dopamine increase by the medial prefrontal cortex

In-vivo microdialysis study showed that the intra-nucleus accumbens injection of mGluR group II antagonist was able to restore methamphetamine induced DA increase suppressed by the overexpression of Shati/Nat8l in the medial prefrontal cortex.

Open Access

Possible association between photic sneeze syndrome and migraine and psychological distress

  • Pages: 217-222
  • First Published: 09 July 2019
Possible association between photic sneeze syndrome and migraine and psychological distress

Our data obtained through a self-report questionnaire administered to 11,840 participants showed that individuals with photic sneeze syndrome were more likely to suffer from migraine and psychological distress than those without photic sneeze syndrome. Photic sneeze syndrome may be a potential target for the research of migraine and stress-related disorders.

Open Access

Comprehensive behavioral analysis of heterozygous Syngap1 knockout mice

  • Pages: 223-237
  • First Published: 19 July 2019
Comprehensive behavioral analysis of heterozygous Syngap1 knockout mice

In Syngap1−/+ mice, a well-known model of SYNGAP-related ID, we could reproduce most of the previously reported cognitive and emotional deficits. The decreased sensitivity to painful stimuli and impaired motor function that we found in Syngap1−/+ mice are consistent with the common characteristics of patients with SYNGAP-related ID. We further confirmed that the Syngap1 heterozygote mouse recapitulates the symptoms of ID and ASD patients.

MICRO REPORTS

Open Access

Dietary intake of glucoraphanin prevents the reduction of dopamine transporter in the mouse striatum after repeated administration of MPTP

  • Pages: 247-251
  • First Published: 27 May 2019
Dietary intake of glucoraphanin prevents the reduction of dopamine transporter in the mouse striatum after repeated administration of MPTP

Oxidative stress plays a role in the neurotoxicity of MPTP in the striatum. Dietary intake of glucoraphanin could prevent the MPTP-induced neurotoxicity in mouse striatum. Dietary intake of glucoraphanin-rich vegetables may have beneficial effects on prevention of Parkinson's disease.

Open Access

Suvorexant for insomnia in patients with psychiatric disorder: A 1-week, open-label study

  • Pages: 252-255
  • First Published: 08 July 2019
Suvorexant for insomnia in patients with psychiatric disorder: A 1-week, open-label study

This is one-week, prospective, single-arm, clinical trial of fixed dose of suvorexant for insomnia included 57 patients with psychiatric disorders. Compared with the baseline scores, taking suvorexant was associated with significant improvements in total sleep time, time to sleep onset, wake time after sleep onset, and the patients' sleep satisfaction level at week 1.

Open Access

Quetiapine extended-release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis

  • Pages: 256-259
  • First Published: 08 July 2019
Quetiapine extended-release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis

We conducted a Bayesian analysis of data from phase 3 studies in Japan of quetiapine extended-release, 300 mg/d (QUEXR300), and olanzapine, 5-20 mg/day (OLA). Although the two drugs’ efficacy did not differ, OLA increased the risk of metabolic syndrome and QUEXR300 the risk of somnolence.